A complete and comprehensive range of poultry vaccines is available. In addition, ABIC manufactures various bovine, sheep and goat vaccines. Vaccines account for 45% of the company's total sales.

The M.B. strain of Gumboro vaccine, which was recently developed by ABIC, is an intermediate live vaccine strain also used as an inactivated oil-emulsion vaccine for the prevention of Infectious Bursal Disease. The intermediate strain was developed to provide protection against the new field epidemic virus, which is much more virulent than those previously encountered.

The V.H. strain of Newcastle disease vaccine is a lentogenic strain and causes no side effects. It has been proven to be safe and effective when applied by aerosol, coarse spray, drinking water or eye-drop routes. It has been used successfully under various management and climactic conditions in many breeds of birds from 1 day-of-age.

QuinAbic^® is ABIC’s patented new third generation quinolone. QuinAbic is produced as a water-soluble powder and as an oral solution for poultry. It is also produced as solutions for administration by way of injection to pigs, cattle and sheep. This antibacterial drug is very effective against gram-positive and gram-negative bacteria and Mycoplasma species.

BromoSept^® and SeptAbic^® are broad-spectrum antibacterial agents that are active against gram-negative and, gram-positive bacteria. SeptAbic has excellent anti-fungal properties and is highly active against bacteria, yeasts, fungi, viruses and algae. This disinfectant is very potent in low concentrations.